Gentamicin Injection USP 40 mg/mL (80mg/2mL) – Alternative product filling shortage may cause airway irritation if administered via inhalation

Important information on changes to the design of Salbutamol (Ventolin) metered dose inhalers (MDIs/‘puffers’) in Australia.

The Patient Clinical Interaction Assessment (PCIA) is being introduced in 2025 to address the gap left when the patient clinical interaction was removed from the medical viva (in 2020).

Patient experience survey (anaesthesia) - guideline

Defects in co-axial (Bain) circuits have been known to occur and to cause patients to develop severe hypercapnia.

Breached seal in packaging of BD Connecta Stopcock with extension tube resulting in loss of sterility of the product

Product defect: Potential for camera and/or LED optical window lens cover to become detached on KARL STORZ C-Mac Video Laryngoscope Blades 8403 series.

Tranexamic acid deaths resulting from similar labelling to other anaesthetics

LINK Healthcare has advised that, due to a shortage of Australian registered DBL GENTAMICIN 10mg/1mL (as sulfate) injection BP ampoule (AUST R 16339), LINK has arranged the supply of an alternative product REFOBACIN (gentamicin) 10mg (10 mg/2mL) ampoules, registered and market...

The TGA has advised of shortage of corticosteriods